Molecular Partners AG
NASDAQ:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
NASDAQ:MOLN
Watchlist
Price: 4.34 USD -5.45% Market Closed
Market Cap: 144m USD

Wall Street
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 13.29 USD with a low forecast of 7.52 USD and a high forecast of 19.55 USD.

Lowest
Price Target
7.52 USD
73% Upside
Average
Price Target
13.29 USD
206% Upside
Highest
Price Target
19.55 USD
350% Upside
Molecular Partners AG Competitors:
Price Targets
6628
Transcenta Holding Limited
553% Upside
SNDX
Syndax Pharmaceuticals Inc
85% Upside
ADOC
Adocia SA
142% Upside
STOK
Stoke Therapeutics Inc
4% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
29% Upside
BMEA
Biomea Fusion Inc
462% Upside
SLS
Sellas Life Sciences Group Inc
152% Upside
RXRX
Recursion Pharmaceuticals Inc
64% Upside

Revenue
Forecast

Revenue Estimate
Molecular Partners AG

For the last 10 years the compound annual growth rate for Molecular Partners AG's revenue is -15%. The projected CAGR for the next 4 years is 79%.

-15%
Past Growth
79%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOLN's stock price target?
Price Target
13.29 USD

According to Wall Street analysts, the average 1-year price target for MOLN is 13.29 USD with a low forecast of 7.52 USD and a high forecast of 19.55 USD.

What is Molecular Partners AG's Revenue forecast?
Projected CAGR
79%

For the last 10 years the compound annual growth rate for Molecular Partners AG's revenue is -15%. The projected CAGR for the next 4 years is 79%.

Back to Top